Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

ClinicalTrials.gov ID: NCT01484522

Public ClinicalTrials.gov record NCT01484522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Laboratory Study to Assess the Immunogenicity of Three Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-1 Perinatally Infected Children and Youth

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to evaluate the immune response to the H1N1 influenza or "flu" vaccine. The "immune response" is how your body recognizes and defends itself against bacteria, viruses, and substances that may be harmful to the body. HIV-1 infected children typically respond more poorly to vaccines compared to uninfected, healthy children and so this study hopes to learn whether or not the body will successfully produce enough antibodies (proteins that fight infection) that will prevent or fight the H1N1 flu virus. There is no information yet on the safety or immune response to this vaccine in children infected with HIV.

Study identification

NCT ID
NCT01484522
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
149 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Months to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Type not available)
Primary completion
Jan 2010 (Actual)
Completion
Sep 2010 (Actual)
Last update posted
Dec 2, 2011

2009 – 2010

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Univ. of Alabama Birmingham NICHD CRS (5096) Birmingham Alabama 35294 —
USC/Los Angeles County Medical Center NICHD CRS Los Angeles California 90033 —
University of California San Francisco NICHD CRS (5091) San Francisco California 94143 —
University of Colorado Denver NICHD CRS (5052) Aurora Colorado 80045 —
University of Miami Pediatric/Perinatal HIV/AIDS (4201) Miami Florida 33136 —
University of South Florida Tampa (5018) Tampa Florida 33620 —
Chicago Children's CRS (4001) Chicago Illinois 60614 —
Children's Hospital of Boston NICHD CRS (5009) Boston Massachusetts 02115 —
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01605 —
Wayne State University/Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201 —
NJ Med School CRS (2802) Newark New Jersey 07103 —
New York University NY (5012) New York New York 10016 —
SUNY Stony Brook (5040) Stony Brook New York 11794-8111 —
Jacobi Medical Center Bronx (5013) The Bronx New York 10461 —
The Children's Hospital of Philadelphia (6701) Philadelphia Pennsylvania 19104 —
St. Jude/UTHSC CRS (6501) Memphis Tennessee 38105-2794 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01484522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2011 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01484522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →